Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

hormonal · Mechanism Report

Can higher SHBG contribute to androgen deficiency in men?

Higher SHBG can lower free and bioavailable testosterone and contribute to androgen deficiency in men.

PlausibleNovember 21, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Higher sex hormone-binding globulin reduces circulating free and bioavailable testosterone and can contribute to androgen deficiency in men.

laying out figure…
3 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

SHBG binds testosterone, reducing the fraction available to the body at a given total testosterone level. As a result, free testosterone can be low even when total testosterone is normal or high.

Verified conclusion

Higher sex hormone-binding globulin (SHBG) can make total testosterone an incomplete indicator of androgen status in men. By tightly binding testosterone, elevated SHBG lowers the circulating fraction that is free or bioavailable, potentially leaving total testosterone normal or high despite reduced physiologically available hormone.

Clinical and biochemical evidence

  • The binding relationship is well established: at the same total testosterone and albumin concentration, higher SHBG reduces free testosterone and bioavailable testosterone (free plus albumin-bound), because SHBG-bound testosterone is excluded from these fractions.
  • In a prospective selected study of 20 men with SHBG >100 nmol/L, 15 had low free testosterone. Of these 15, eight had total testosterone >450 ng/dL and four had values above the study’s upper reference limit—illustrating how elevated SHBG can mask low free testosterone when total testosterone is used alone.
  • In the European Male Ageing Study of community-dwelling men aged 40–79, men with normal total but low calculated free testosterone had higher SHBG and more sexual symptoms and physical limitations than men with normal total and free testosterone, including after adjustment for age, BMI, comorbidity, and study center.

Mechanism and measurement

  • SHBG’s high-affinity binding shifts testosterone into an unavailable bound pool; this can increase measured total testosterone while decreasing the free fraction.
  • Free testosterone is best assessed by equilibrium dialysis or a validated calculation incorporating total testosterone, SHBG, and albumin. Direct analog free-testosterone immunoassays are unreliable, especially when SHBG is abnormal.

Clinical implications

  • Androgen deficiency requires compatible symptoms/signs plus consistently low testosterone on reliable fasting morning testing, usually on at least two occasions.
  • Bottom line: Elevated SHBG can contribute to clinically relevant androgen deficiency despite non-low total testosterone; SHBG-aware free-testosterone assessment is essential in this setting.

References

  1. Hormonal profiles of men with highly elevated SHBG ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  2. Laboratory Assessment of Testicular Function - Endotext - NCBI - NIH — ncbi.nlm.nih.gov ↗
  3. Reassessing Free-Testosterone Calculation by Liquid ... — pubmed.ncbi.nlm.nih.gov ↗
  4. A Reappraisal of Testosterone’s Binding in Circulation: Physiological and Clinical Implications — ncbi.nlm.nih.gov ↗
  5. A. Salonia (Chair), C. Bettocchi, P. Capogrosso, J. Carvalho, — d56bochluxqnz.cloudfront.net ↗
  6. Testosterone therapy in men with hypogonadism: an Endocrine Society ... — albme.gov ↗
  7. Low free testosterone is associated with hypogonadal signs and ... — pmc.ncbi.nlm.nih.gov ↗
  8. Male Hypogonadism - EAU Guidelines on Sexual and Reproductive … — uroweb.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible4 sourcesDoes FSH rise as ovarian function declines during the menopausal transition?→Plausible14 sourcesCan estrogen or progesterone use affect hormone panel results?→